Organon & Co. (OGN) is close to being acquired by Sun Pharmaceutical Industries, which is moving ahead with a binding $12 billion cash offer for the pharmaceutical company, The Economic Times reported Friday.
Sun Pharmaceutical has conducted due diligence on the acquisition and is finalizing financing for the deal, according to the report, which cited sources with knowledge of the proposed transaction.
Sun Pharmaceutical and Organon did not immediately respond to requests for comment from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Comments